A prescription medicine offered with no prescription
It is illegal, as of September 2026, to sell a prescription drug to someone who has no prescription for it.
Source B
Safety primer
Healthy aging injections: careful with the source
Safety starts before anything reaches the skin. Check the product, the prescriber (the doctor or nurse who writes the prescription), and the pharmacy. Then follow the exact label and care instructions.
Before treatment
A needle can carry germs straight into the body
FDA has warned sellers that injected products can cause serious harm, because they go through the skin and skip some of the body’s defences against germs and poisons.
That makes the source and the way the medicine was made central safety questions, not paperwork.
Source AStep away when the care path is missing
A research chemical sold with mixing water and dosing notes
If the real offer is a product for people to inject, printing “research use only” on it does not turn it into a lawful treatment (as of September 2026).
Source CA questionnaire that cannot ask a follow-up
As of September 2026, state medical board policy says an online questionnaire alone is not a proper medical check when it cannot gather the details needed.
Source DA compound called FDA-approved
As of September 2026, a compounded medicine described as FDA-approved is being described falsely.
Source E
At home
Use the exact storage instructions
Each medicine has its own storage rules. Some peptide medicines stay at room temperature, while others need refrigeration.
Follow the product label and the directions from the pharmacy that filled your prescription.
Source F
USED SHARPS
Contain them at once
FDA says loose used needles belong in a proper sharps container, never in household trash, recycling, or a toilet.
Source G
Urgent help
A severe allergic reaction is an emergency
Signs of a severe reaction can include a hard time breathing or swallowing, a swollen face or tongue, fainting, and hives that spread fast.
Call 911 or the local emergency number for severe symptoms.
This is a prompt to get urgent help, not a way to diagnose a reaction from a page.
Source H
After a problem
Keep the label and report what happened
FDA’s MedWatch program accepts reports from patients and consumers about problems with medical products.
Keep the medicine label, packaging, pharmacy name, and any care messages together. Those details help identify the product involved.
Source IFor non-urgent concerns
Contact the prescriber and the pharmacy that filled the prescription. Share the exact product name and what changed.
For urgent symptoms, use emergency care instead of waiting for an online reply.
Return to the start
Back to the guide
Bring the product, care, cost, source, and safety checks together.
Page notes
Source A. FDA warning letter on injectable research products.
Source B. The federal prescription-drug law in the Food, Drug, and Cosmetic Act.
Source C. FDA warning letter on research-labelled products.
Source D. State medical boards’ telemedicine policy.
Source E. FDA compounding questions and answers.
Source F. Product labels on file with FDA, and the MedlinePlus medicine guide from the National Library of Medicine.
Source G. FDA sharps guidance.
Source H. National Library of Medicine emergency guide.
Source I. FDA MedWatch.